Angiotensin Ii receptor blockers - pilot experience and nephrology perspectives
Shevtsov, M.I.
Terapevticheskii Arkhiv 72(6): 73-79
2000
ISSN/ISBN: 0040-3660 PMID: 10900660 Document Number: 518509
Document emailed within 1 workday
Related Documents
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin converting enzyme inhibitors and angiotensin Ii receptor blockers on angiogenesis of gastric cancer in a nude mouse model Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 565-568
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin-converting enzyme inhibitors and angiotensin Ii type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model Chinese Medical Journal 121(21): 2167-2171
Vijan, S.G. 2009: Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients Journal of the Indian Medical Association 107(3): 178-182
Aoyama, N. 2007: Effect of combination therapy with angiotensin Ii type i receptor and aldosterone receptor blockers in heart failure Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 145-149
Lommi, J. 2005: Angiotensin II-receptor blockers Duodecim; Laaketieteellinen Aikakauskirja 121(6): 589-592
Fruhwald, F.M.; Kickenweiz, E.; Zweiker, R.; Klein, W. 2001: Angiotensin i receptor blockers for heart failure Wiener Medizinische Wochenschrift 151(7-8): 157-159
Oganov, R.G.; Nebieridze, D.V. 2002: Metabolic effects of angiotensin-Ii receptor blockers Kardiologiia 42(3): 35-39
Sabbah, Z.A.; Mansoor, A.; Kaul, U. 2013: Angiotensin receptor blockers - advantages of the new sartans Journal of the Association of Physicians of India 61(7): 464-470
Ol'binskaia, L.I.; Morozov, I.A. 1996: Angiotensin-Ii receptor blockers in the treatment of arterial hypertension Eksperimental'naia i Klinicheskaia Farmakologiia 59(5): 76-80
Kumar, S.; Ram, C.V.S. 2007: Angiotensin receptor blockers: current status and future prospects Indian Heart Journal 59(6): 443-453
Raatikainen, M.J.; Huikuri, H.V. 2003: Are ACE inhibitors and angiotensin receptor blockers useful in the treatment of atrial fibrillation? Duodecim; Laaketieteellinen Aikakauskirja 119(16): 1505-1507
Dang, A.-m.; Liu, G.-z.; Zhang, Y.-h.; Chen, G.-l. 2006: The effects of angiotensin Ii receptor blockers in hypertensive patients complicating hyperuricaemia Zhonghua Xin Xue Guan Bing Za Zhi 34(10): 882-885
Vaquero Roncero, L.M.; Julián González, R.; Muriel Villoria, C. 2004: Refractory hypotension during anesthesia in a patient treated with angiotensin receptor blockers Revista Espanola de Anestesiologia y Reanimacion 51(6): 338-341
Spinar, J.; Vítovec, J.; Soucek, M.; Dusek, L.; Pavlík, T. 2009: CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin Ii receptor blockers Vnitrni Lekarstvi 55(5): 481-488
Schiffrin, E.L. 2002: Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers Canadian Journal of Cardiology 18 Suppl A: 15a-18a
Gao, P.; Jia, R.-h.; Yang, D.-p.; Liu, H.-y.; Song, E.-f.; Chu, G.-l.; Ding, G.-h. 2005: Renoprotective effect of combining angiotensin Ii receptor blockers and statins in diabetic rats Chinese Medical Journal 118(7): 598-602
Pongsuthana, S.; Chutpongtada, K. 2016: A Comparison of the Efficacy and Renal Side Effects of Antihypertensive Drugs "Angiotensin Receptor Blockers" (ARBs) in Rajavithi Hospital Journal of the Medical Association of Thailand 99(Suppl 2): S56-S62
de la Fuente Cid, R.; Varela Román, A. 2007: Which is the role of the angiotensin II receptor blockers (ARBs) for the treatment of heart failure? Do we work based on evidence/recommendations or pharmaceutical industry pressure? Anales de Medicina Interna 24(12): 607-609
Tsuyuki, R.T.; Yusuf, S.; Rouleau, J.L.; Maggioni, A.P.; McKelvie, R.S.; Wiecek, E.M.; Wang, Y.; Pogue, J.; Teo, K.K.; White, M.; Avezum, A.; Latini, R.; Held, P.; Lindgren, E.; Probstfield, J. 1997: Combination neurohormonal blockade with ACE inhibitors, angiotensin Ii antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study Canadian Journal of Cardiology 13(12): 1166-1174